EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
137 hedge funds and large institutions have $1.17B invested in Eagle Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+21
Holders Change %
+18.1%
% of All Funds
3.66%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
49
Increased
36
Reduced
33
Closed
28
Calls
$17.5M
Puts
$6.33M
Net Calls
+$11.2M
Net Calls Change
+$7.1M
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$48.3M |
| 2 |
First Eagle Investment Management
New York
|
+$39.8M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$25.1M |
| 4 |
PC
PointState Capital
New York
|
+$21.3M |
| 5 |
JCI
Jet Capital Investors
New York
|
+$9.44M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$29.6M |
| 2 |
PAI
ProQuest Associates IV
Naples,
Florida
|
-$27.8M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$21.3M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$18.7M |
| 5 |
GE
General Electric
Evendale,
Ohio
|
-$13.1M |
